IP Transactions

“The Future of Licensing Deals or Are We All Doing Acquisitions Now? Review From a Commercial Perspective” – Ms. Cox introduced the first ever joint LES/PLG (Pharmaceutical Licensing Group) panel at LESI. The panel shared deal trends and comments about licensing vs. acquisition from both the corporate perspective and the VC perspective. Pamela Demain from Merck and President of LES USA/Canada, moderated this panel and was joined by Sharon Finch from Medius Associates, Reginald Seeto from MedImmune, and Edward van Wezel from Biogeneration Ventures.